Sensors in Medicine 2021, the 9th in this annual series and the 2nd in virtual space, is not the largest conference on biosensors but arguably is the most important because it deals specifically with innovative applications in medicine and healthcare. Established biosensor applications in pregnancy testing and diabetes monitoring are now joined by infectious disease, cancer and other diagnostic tests. New Point of Care tests, Linear Flow platforms, Wearable and Implantable biosensors now appear almost daily.
SiM21 seeks to highlight the most innovative advances in biosensor applications in medicine and healthcare. We would like to hear from you if you have developed medical and healthcare biosensor applications, at any stage of development:
Sensor technology, electrochemical, optical and other methods
Sensor systems in which biosensors are incorporated such as PoC or microfluidics
Wearable, implantable or ingestible biosensors
Early stage companies seeking partnerships or finance
In addition to a program or invited and contributed presentations, the Conference will include:
Panel discussions on the future direction of biosensor research and barriers to commercial adoption
Poster displays of student research, with a competition judged by Conference delegates
Exhibition of innovative biosensor applications and support organisations
Registration fees are waived for post-graduate students who present posters - the student must be full-time enrolled in a higher degree program. Written evidence may be required.
Contact us at sim21@sensor100.com to participate in the Conference.
Organising Committee
Prof H Thomas Aretz MD, Harvard Medical School and Partners International
Dr Michael Brand, Sensor100
Prof Jonathan Cooper, University of Glasgow Department of Bioengineering
Dr. Pedro Estrela, C3Bio, University of Bath